Hawthorn and Cypress Pharmaceuticals announced that the FDA has approved Zutripro (hydrocodone bitartrate, chlorpheniramine maleate, and pseudoephedrine HCl oral solution) and Rezira (hydrocodone bitartrate and pseudoephedrine oral solution) for the relief of cough and nasal congestion associated with the common cold in adults ≥18 years. Zutripro is also indicated for relief of upper respiratory allergy symptoms in adults.

Zutripro and Rezira are C-III controlled substances, and will be available by prescription.

For more information call (888) 455-5253 or visit www.hawthornrx.com.